Revvity, Inc. (RVTY)
Revvity, Inc. (RVTY) is a global provider of laboratory testing, diagnostic products, and healthcare solutions. The company focuses on advancing scientific research and medical diagnostics through innovative technologies and comprehensive testing services, supporting healthcare providers and research institutions worldwide.
Dividend History
Investors can expect a dividend payout of $0.07 per share, scheduled to be distributed in 48 days on November 7, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 7, 2025 | $0.07 | 2025-10-17 | 2025-10-17 |
| August 8, 2025 | $0.07 | 2025-07-18 | 2025-07-18 |
| May 9, 2025 | $0.07 | 2025-04-17 | 2025-04-18 |
| February 7, 2025 | $0.07 | 2025-01-17 | 2025-01-17 |
| November 8, 2024 | $0.07 | 2024-10-18 | 2024-10-18 |
Dividends Summary
- Revvity, Inc. has issued 88 dividend payments over the past 21 years
- The most recent dividend was paid 43 days ago, on August 8, 2025
- The highest dividend payed out to investors during this period was $0.07 per share
- The average dividend paid during this period was $0.07 per share.
Company News
Revvity reported Q2 earnings beating estimates but lowered fiscal year 2025 guidance due to challenging macroeconomic conditions and China's new hospital laboratory reimbursement policy, which is impacting its immunodiagnostics business.
Revvity reported Q2 2025 financial results with $720 million revenue, exceeding estimates, but experiencing margin compression and slight earnings decline due to tariff pressures and challenging market conditions.
The global CRISPR gene editing market is projected to grow from USD 4.15 billion in 2024 to USD 16.47 billion by 2034, driven by technological advancements, increasing investments, and growing applications in biotechnology and healthcare.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
